StockData

Electromedical Technologies, Inc (EMED) stock

EMEDOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2024, quý kết thúc ngày Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$0.00+0.00 (+9900.00%)

Close on Oct 19, 2026Market cap $68.10KP/E –Yield –

Electromedical Technologies, Inc saw revenue fall 35.1% to $922.01K over the twelve months to Sep 30, 2024. Free cash flow was -$1.57M. At the latest close the market valued the company at $68.10K.

Revenue
$922.01K
-35.1% vs. a year earlier
Operating income
-$1.01M
TTM Q3 2024
Free cash flow
-$1.57M
FY2023
EPS, diluted
-$0.00
TTM Q3 2024

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2024

Valuation

Market cap
$68.10K
P/E ratio
–
Price to sales
0.07
Price to book
–
Dividend yield
–
Free cash flow yield
-2301.17%

Fundamentals

Revenue
$922.01K
Net income
-$1.68M
EPS, diluted
-$0.00
Free cash flow
-$1.57M
Book value per share
-$0.01
Diluted shares
681M

Trading

Previous close
$0.00
Open
$0.00
Day's range
$0.00 – $0.00
Volume
9,850,000
Average volume (20 days)
6,924,992

Market cap history

Month-end market cap since 2020, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodEMEDS&P 500DifferenceEMED per yearS&P 500 per year
1 month0.0%+0.6%−0.6 pts
3 months0.0%+3.4%−3.4 pts
Year to date-50.0%+13.3%−63.3 pts
1 year0.0%+16.6%−16.6 pts
3 years-85.7%+86.4%−172.1 pts-47.7%+23.1%
5 years-99.9%+81.9%−181.8 pts-76.4%+12.7%

Six years at a glance

Fiscal years 2018 to 2023 and trailing twelve months, USD

Revenue

$922.01K-35.1% YoY

Gross profit

$692.23K-37.5% YoY

Operating income

-$1.01M

Net income

-$1.68M

EPS, diluted

-$0.00

Free cash flow

–
Reported periodTrailing twelve months

About Electromedical Technologies

Surgical & Medical Instruments & Apparatus

Electromedical Technologies manufactures and markets bioelectronic medical devices designed for drug-free pain relief. Its flagship product is the WellnessPro Plus, an FDA-cleared transcutaneous electrical nerve stimulation device that delivers proprietary electrical frequencies to manage chronic and acute pain conditions. The business also develops additional bioelectric products, such as the WellnessPro POD wearable and the Wellness ION Pen cold-laser system. Its products serve individual consumers and healthcare practitioners, including chiropractors, physiotherapists, and specialists in pain management, natural medicine, and sports medicine.

Company profile, executives and history

Electromedical Technologies stock: common questions

What is Electromedical Technologies's stock price?

EMED closed at $0.00 on Oct 19, 2026, up 9900.00% on the day.

What is Electromedical Technologies's market cap?

Electromedical Technologies was worth $68.10K at the close on Oct 19, 2026: the share price times the diluted shares outstanding.

What is EMED's P/E ratio?

Electromedical Technologies lost money over the twelve months to Sep 30, 2024 (diluted EPS -$0.00), so it has no meaningful P/E ratio.

How much revenue does Electromedical Technologies make?

Electromedical Technologies reported revenue of $922.01K for the twelve months to Sep 30, 2024, down 35.1% from a year earlier.

Does Electromedical Technologies pay a dividend?

No. Electromedical Technologies has not paid a cash dividend over the last twelve months.

How has EMED stock performed over the past year?

Including dividends, EMED returned 0.0% over the past year, against +16.6% for the S&P 500.

Who are Electromedical Technologies's competitors?

Companies most similar to Electromedical Technologies by business, industry and size include STME, NMTC, SNWV, SNOA, TCMD.

See a number that looks wrong?